Vape News

FDA Commissioner Marty Makary Resigns Amid Dispute Over Flavored Vape Approvals

FDA Commissioner Resigns Amid Flavored Vape Approval Dispute

Key Points

  • Marty Makary Resigns as FDA Commissioner

U.S. FDA Commissioner Marty Makary resigned on May 12.

  • Dispute Over Fruit-Flavored Vapes Reportedly Triggered Departure

According to The New York Times, Makary’s opposition to the approval of fruit-flavored vapes was one of the key reasons for his resignation.

  • White House and FDA Divided on Vape Regulation

The White House had previously pushed the FDA to expand the scope of authorized flavored vapes, whereas Makary opposed such policies.

  • FDA Recently Relaxed Vape Marketing Policies

This month, the FDA has already authorized two fruit-flavored vape products and further relaxed marketing regulations.

  • Makary Faced Multiple Political and Industry Conflicts

During his tenure, Makary frequently clashed with groups representing the tobacco, food, and pharmaceutical industries, as well as anti-abortion advocates.

  • Kyle Diamantas Appointed Acting FDA Commissioner

Kyle Diamantas, head of the FDA’s food division, will serve as Acting Commissioner.


Marty Makary Steps Down as FDA Commissioner

May 13, 2026. According to The New York Times, U.S. Food and Drug Administration (FDA) Commissioner Marty Makary resigned on May 12, following weeks of persistent rumors that the Trump administration was planning to dismiss him.

Opposition to Flavored Vapes Reportedly Played a Key Role

Citing four sources familiar with the matter, the report states that a major factor contributing to Makary’s eventual resignation was his opposition to the Trump administration’s approval of fruit-flavored vape products.

The sources indicated that Makary had explicitly told those around him that, given the appeal of fruit- and candy-flavored vapes to adolescents, he “could not in good conscience” authorize such products.

This resignation comes at a time when internal divisions within the U.S. government, centered on harm reduction via vapes, the risks of youth usage, and the regulation of flavored products, are intensifying.

White House Pushes for Expanded Flavored Vape Approvals

The New York Times reports that the Trump administration has recently been pressuring the FDA to expand the scope of authorized flavored vape products.

Earlier this month, the FDA authorized two fruit-flavored vape products. Subsequently, last Friday, the FDA issued further policy guidance allowing for the broader marketing of relevant products.

Makary, however, has long maintained a cautious stance regarding the approval of flavored vapes, expressing concern that fruit and candy flavors could entice young people to start using nicotine products.

Previously, The Wall Street Journal reported that the White House had been pressuring the FDA to approve more flavored vape products, with Makary emerging as one of the primary sources of internal resistance.

The Trump administration, for its part, views expanding the range of flavored vape options available to adults as an integral component of its harm-reduction strategy.

Makary’s Tenure Marked by Reform Efforts and Controversies

Before his tenure at the agency, Makary served as a cancer surgeon and health policy researcher at Johns Hopkins University.

During his time as FDA Commissioner, he championed several reform initiatives, including adjustments to policies regarding natural food colorings and updates to certain regulations concerning hormone replacement therapy for women.

However, his tenure was also marked by persistent controversy.

Reports indicate that Makary drew criticism from the public health community for issuing a memo that lacked sufficient evidentiary support regarding deaths allegedly linked to COVID-19 vaccines.

Furthermore, he authorized the re-entry into the market of certain peptide-based injectable products that had not undergone rigorous validation, a policy that garnered support from U.S. Secretary of Health Robert F. Kennedy Jr.

Concurrently, anti-abortion groups criticized Makary for stalling progress on research into the safety of mifepristone, an abortion medication.

FDA Workforce Restructuring Added to Leadership Turmoil

During Makary’s leadership, the FDA also underwent a massive internal restructuring of its workforce.

According to reports, U.S. Secretary of Health Robert F. Kennedy Jr., alongside the “Department of Government Efficiency” (DOGE), led by Elon Musk, pushed for significant staff reductions at the FDA. These cuts affected positions across various divisions, including medical device review, food safety, and drug safety monitoring.

Although some employees were subsequently rehired, the FDA’s overall workforce ultimately shrank by more than 4,000 employees, accounting for approximately one-fifth of its total staff.

Makary later reversed course to advocate for a resumption of hiring, pushing for the FDA to fill approximately 3,000 vacant positions; however, the hiring process has proceeded slowly.

Kyle Diamantas Named Acting FDA Commissioner

The New York Times has reported that Kyle Diamantas, the head of the FDA’s food division, will serve as Acting Commissioner.

Diamantas previously worked at the law firm Jones Day, where he represented Abbott Nutrition, a manufacturer of infant formula.

Uncertainty Remains Over the Future of U.S. Vape Regulation

Industry insiders believe that Makary’s departure could further alter the trajectory of vape regulation in the United States.

Currently, two distinct policy paths continue to exist within the U.S. government:

One side emphasizes promoting harm reduction among adult smokers through alternative products, such as flavored vapes; the other expresses concern that such products may heighten the risk of nicotine use among adolescents.

Analysts note that the FDA’s future approach to approving flavored vapes, nicotine pouches, and other novel nicotine products will remain subject to the ongoing interplay among the White House, public health agencies, and industry interest groups.

Follow us to get more updates: @zumo.official

Share article

Filed in: Best Vapes, Online Vape Store, Prefilled Vape, Product Review, Rechargeable Vape, Top Vapes, Vape Kits, Vape Pods, Vape Shop, Vaping, OEM/ODM, Custom Vape

Contact Us
Fill out this field
Please enter a valid email address.
Fill out this field
Fill out this field
Previous article
FDA Starts Review of VLN Low-Nicotine Cigarette Renewal
Next article
Ispire and Jincheng Pharmaceutical Form Joint Venture for Nicotine Pouches

Hot Article